Deepak R. Talreja, MD, discusses the current advances in lipidology. Here he discusses lipid management that utilizes PCSK9 inhibitors, how these effect cholesterol, how to determine if your patient is a candidate for this type of treatment, and what complications one might expect from this treatment.